Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001104659-25-072162
Filing Date
2025-07-30
Accepted
2025-07-30 16:12:25
Documents
12
Period of Report
2025-09-10

Document Format Files

Seq Description Document Type Size
1 PREM14A tm2520986-4_prem14a.htm PREM14A 3362266
2 EX-FILING FEES tm2520986d4_ex-filingfees.htm EX-FILING FEES 37592
3 GRAPHIC ft_leerinkpartners-4c.jpg GRAPHIC 14058
4 GRAPHIC lg_essa-4c.jpg GRAPHIC 9621
5 GRAPHIC lg_leerinkpartners-4c.jpg GRAPHIC 11629
6 GRAPHIC px_essapharmaproxy1pg01-bw.jpg GRAPHIC 382576
7 GRAPHIC px_essapharmaproxy1pg02-bw.jpg GRAPHIC 393110
8 GRAPHIC px_essapharmaproxy1pg03-bw.jpg GRAPHIC 381439
9 GRAPHIC px_essapharmaproxy1pg04-bw.jpg GRAPHIC 250362
10 GRAPHIC px_essapharmaproxy1pg05-bw.jpg GRAPHIC 381685
11 GRAPHIC px_essapharmaproxy1pg06-bw.jpg GRAPHIC 250416
12 GRAPHIC sg_leerinkpartnersllc-bw.jpg GRAPHIC 7270
  Complete submission text file 0001104659-25-072162.txt   6208378
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: PREM14A | Act: 34 | File No.: 001-37410 | Film No.: 251167171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)